Achieve Life Sciences (ACHV) Short-term Investments (2010 - 2026)

Achieve Life Sciences has disclosed Short-term Investments across 13 years of filings, most recently posting $1.2 million for Q1 2026.

• Quarterly Short-term Investments fell 88.36% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 88.36% YoY) and the FY2025 annual result came in at $15.5 million, down 28.38% from the prior year.
• Short-term Investments fell to $1.2 million in Q1 2026, from $15.5 million in the prior quarter.
• Over five years, Short-term Investments peaked at $46.6 million in Q2 2024 and troughed at $1.2 million in Q1 2026.
• A 3-year average of $18.5 million and a median of $15.8 million in 2025 frame the typical range for Short-term Investments.
• Biggest YoY gain for Short-term Investments was 28.38% in 2025; the steepest drop was 92.43% in 2025.
• Tracing ACHV's Short-term Investments over 3 years: stood at $21.6 million in 2024, then decreased by 28.38% to $15.5 million in 2025, then plunged by 92.3% to $1.2 million in 2026.
• Business Quant data shows ACHV's Short-term Investments at $1.2 million in Q1 2026, $15.5 million in Q4 2025, and $16.2 million in Q3 2025.